{
  "Company_Combined": {
    "shape": [
      273,
      7
    ],
    "columns": [
      "Company",
      "Active_Individuals",
      "Dominant_Topic",
      "Team_Buying_Signal",
      "Behavioral_Triggers",
      "External_Trigger",
      "Product_Category"
    ],
    "head": [
      {
        "Company": "3Pbiovian",
        "Active_Individuals": 1,
        "Dominant_Topic": "Biologic,Discovery,How Sethera Harnesses A Promiscuous Enzyme To Make Recombinant Peptides",
        "Team_Buying_Signal": "No",
        "Behavioral_Triggers": "",
        "External_Trigger": "",
        "Product_Category": "Biologic,Discovery,How Sethera Harnesses A Promiscuous Enzyme To Make Recombinant Peptides"
      },
      {
        "Company": "A*Star",
        "Active_Individuals": 1,
        "Dominant_Topic": "Antibodies-(mAbs,Bio-Expo Live: Downstream Bioprocessing - November 2025,Cell Therapy",
        "Team_Buying_Signal": "No",
        "Behavioral_Triggers": "GMP / clinical manufacturing",
        "External_Trigger": "",
        "Product_Category": "Antibodies-(mAbs,Bio-Expo Live: Downstream Bioprocessing - November 2025,Cell Therapy"
      },
      {
        "Company": "Abbott",
        "Active_Individuals": 2,
        "Dominant_Topic": "All Molecules,Regulatory,The 7 C's Of A Compliant Manufacturing Change Control System",
        "Team_Buying_Signal": "Yes",
        "Behavioral_Triggers": "GMP / clinical manufacturing",
        "External_Trigger": "",
        "Product_Category": "All Molecules,Regulatory,The 7 C's Of A Compliant Manufacturing Change Control System,& Analytical Solutions - November 2025,Assays,Bio-Expo Live: Bioprocess Quality"
      },
      {
        "Company": "Abbott India Ltd",
        "Active_Individuals": 1,
        "Dominant_Topic": "& Analytical Solutions - November 2025,Bio-Expo Live: Bioprocess Quality,Data",
        "Team_Buying_Signal": "No",
        "Behavioral_Triggers": "GMP / clinical manufacturing",
        "External_Trigger": "",
        "Product_Category": "& Analytical Solutions - November 2025,Bio-Expo Live: Bioprocess Quality,Data"
      },
      {
        "Company": "Abl",
        "Active_Individuals": 1,
        "Dominant_Topic": "Antibodies-(mAbs,Bio-Expo Live: Downstream Bioprocessing - November 2025,Gene Therapy",
        "Team_Buying_Signal": "No",
        "Behavioral_Triggers": "GMP / clinical manufacturing",
        "External_Trigger": "",
        "Product_Category": "Antibodies-(mAbs,Bio-Expo Live: Downstream Bioprocessing - November 2025,Gene Therapy"
      }
    ]
  },
  "Individuals": {
    "shape": [
      349,
      14
    ],
    "columns": [
      "Reader Company",
      "First Name",
      "Last Name",
      "Title",
      "Total Engagements",
      "Buyer_Journey_Label",
      "Explanation",
      "Primary_Topic",
      "Potential_Vendors",
      "Vendors_Evaluated",
      "Buyer_Intensity_Flags",
      "Behavioral_Trigger",
      "External_Trigger (press release info, etc)",
      "Reason to Reach out"
    ],
    "head": [
      {
        "Reader Company": "Abbott",
        "First Name": "Aaron",
        "Last Name": "Comerford",
        "Title": "Medical Device Production Supervisor",
        "Total Engagements": 5,
        "Buyer_Journey_Label": "Awareness",
        "Explanation": "Direct (Non-NL) visit rather than newsletter click \u2022 Exploring process/solution workflows",
        "Primary_Topic": "All Molecules,Regulatory,The 7 C's Of A Compliant Manufacturing Change Control System",
        "Potential_Vendors": "Cytiva, Sartorius, Thermo Fisher Scientific, MilliporeSigma, Repligen, Pall (Cytiva)",
        "Vendors_Evaluated": "",
        "Buyer_Intensity_Flags": "\ud83d\udd25 Non-NL engagement, \ud83d\udd04 Deep process interest",
        "Behavioral_Trigger": "GMP / clinical manufacturing",
        "External_Trigger (press release info, etc)": "",
        "Reason to Reach out": "Early awareness in All Molecules,Regulatory,The 7 C's Of A Compliant Manufacturing Change Control System; keep warm with high-level thought leadership."
      },
      {
        "Reader Company": "Intravacc",
        "First Name": "Aart",
        "Last Name": "Oever",
        "Title": "Bioprocess developer / Researcher DSP",
        "Total Engagements": 25,
        "Buyer_Journey_Label": "Vendor Evaluation",
        "Explanation": "Direct (Non-NL) visit rather than newsletter click \u2022 Engaging with late-stage comparison/evaluation content \u2022 Exploring process/solution workflows \u2022 Looking at challenge/problem-focused content",
        "Primary_Topic": "And Ongoing Frustrations,Bioprocess Manufacturing Controls,Development",
        "Potential_Vendors": "Cytiva, Sartorius, Thermo Fisher Scientific, Repligen, Pall (Cytiva), MilliporeSigma",
        "Vendors_Evaluated": "Bio-Rad, Cytiva, Lonza",
        "Buyer_Intensity_Flags": "\ud83d\udd25 Non-NL engagement, \ud83d\udcc4 Late-stage content, \ud83d\udd04 Deep process interest",
        "Behavioral_Trigger": "GMP / clinical manufacturing, Vendor/option comparison",
        "External_Trigger (press release info, etc)": "",
        "Reason to Reach out": "Actively comparing solutions in And Ongoing Frustrations,Bioprocess Manufacturing Controls,Development; good timing for targeted outreach."
      },
      {
        "Reader Company": "Wacker",
        "First Name": "Aavi",
        "Last Name": "Bhakta",
        "Title": "Process Development Scientist III",
        "Total Engagements": 7,
        "Buyer_Journey_Label": "Solution Exploration",
        "Explanation": "Direct (Non-NL) visit rather than newsletter click \u2022 Exploring process/solution workflows",
        "Primary_Topic": "& Analytical Solutions - November 2025,Bio-Expo Live: Bioprocess Quality,Data",
        "Potential_Vendors": "Waters, Agilent, Thermo Fisher Scientific, SCIEX, Shimadzu",
        "Vendors_Evaluated": "MilliporeSigma",
        "Buyer_Intensity_Flags": "\ud83d\udd25 Non-NL engagement, \ud83d\udd04 Deep process interest",
        "Behavioral_Trigger": "GMP / clinical manufacturing",
        "External_Trigger (press release info, etc)": "",
        "Reason to Reach out": "Early awareness in & Analytical Solutions - November 2025,Bio-Expo Live: Bioprocess Quality,Data; keep warm with high-level thought leadership."
      },
      {
        "Reader Company": "National Research Centre",
        "First Name": "Abdelmageed",
        "Last Name": "Othman",
        "Title": "prof",
        "Total Engagements": 7,
        "Buyer_Journey_Label": "Solution Exploration",
        "Explanation": "Direct (Non-NL) visit rather than newsletter click \u2022 Exploring process/solution workflows \u2022 Looking at challenge/problem-focused content",
        "Primary_Topic": "& Analytical Solutions - November 2025,Bio-Expo Live: Bioprocess Quality,Bioanalytical Methods",
        "Potential_Vendors": "Waters, Agilent, Thermo Fisher Scientific, SCIEX, Shimadzu",
        "Vendors_Evaluated": "MilliporeSigma",
        "Buyer_Intensity_Flags": "\ud83d\udd25 Non-NL engagement, \ud83d\udd04 Deep process interest",
        "Behavioral_Trigger": "GMP / clinical manufacturing",
        "External_Trigger (press release info, etc)": "",
        "Reason to Reach out": "Early awareness in & Analytical Solutions - November 2025,Bio-Expo Live: Bioprocess Quality,Bioanalytical Methods; keep warm with high-level thought leadership."
      },
      {
        "Reader Company": "Amryt Pharma",
        "First Name": "Adi",
        "Last Name": "Valdfogel",
        "Title": "Senior Manager MSAT",
        "Total Engagements": 8,
        "Buyer_Journey_Label": "Solution Exploration",
        "Explanation": "Direct (Non-NL) visit rather than newsletter click \u2022 Exploring process/solution workflows \u2022 Looking at challenge/problem-focused content",
        "Primary_Topic": "Bio-Expo Live: Downstream Bioprocessing - November 2025,Q) What Therapeutic are you working on? A) Proteins & Peptides,Q) What is your anticipated timeframe for purchasing downstream solutions? A) Not needed at this time",
        "Potential_Vendors": "Cytiva, Sartorius, Tosoh Bioscience, Repligen",
        "Vendors_Evaluated": "Bio-Rad, Cytiva, MilliporeSigma",
        "Buyer_Intensity_Flags": "\ud83d\udd25 Non-NL engagement, \ud83d\udd04 Deep process interest",
        "Behavioral_Trigger": "GMP / clinical manufacturing",
        "External_Trigger (press release info, etc)": "",
        "Reason to Reach out": "Early awareness in Bio-Expo Live: Downstream Bioprocessing - November 2025,Q) What Therapeutic are you working on? A) Proteins & Peptides,Q) What is your anticipated timeframe for purchasing downstream solutions? A) Not needed at this time; keep warm with high-level thought leadership."
      }
    ]
  },
  "Sales_Hot_List": {
    "shape": [
      18,
      14
    ],
    "columns": [
      "Reader Company",
      "First Name",
      "Last Name",
      "Title",
      "Total_Engagements",
      "Buyer_Journey_Label",
      "Explanation",
      "Primary_Topic",
      "Potential_Vendors",
      "Vendors_Evaluated",
      "Buyer_Intensity_Flags",
      "Behavioral_Trigger",
      "External_Trigger (press release info, etc)",
      "Reason_to_Reach_Out"
    ],
    "head": [
      {
        "Reader Company": "Intravacc",
        "First Name": "Aart",
        "Last Name": "Oever",
        "Title": "Bioprocess developer / Researcher DSP",
        "Total_Engagements": 25,
        "Buyer_Journey_Label": "Vendor Evaluation",
        "Explanation": "Direct (Non-NL) visit rather than newsletter click \u2022 Engaging with late-stage comparison/evaluation content \u2022 Exploring process/solution workflows \u2022 Looking at challenge/problem-focused content",
        "Primary_Topic": "And Ongoing Frustrations,Bioprocess Manufacturing Controls,Development",
        "Potential_Vendors": "Cytiva, Sartorius, Thermo Fisher Scientific, Repligen, Pall (Cytiva), MilliporeSigma",
        "Vendors_Evaluated": "Bio-Rad, Cytiva, Lonza",
        "Buyer_Intensity_Flags": "\ud83d\udd25 Non-NL engagement, \ud83d\udcc4 Late-stage content, \ud83d\udd04 Deep process interest",
        "Behavioral_Trigger": "GMP / clinical manufacturing, Vendor/option comparison",
        "External_Trigger (press release info, etc)": "",
        "Reason_to_Reach_Out": "Actively comparing solutions in And Ongoing Frustrations,Bioprocess Manufacturing Controls,Development; good timing for targeted outreach."
      },
      {
        "Reader Company": "Hnelius",
        "First Name": "Alex",
        "Last Name": "Song",
        "Title": "ADC SD",
        "Total_Engagements": 18,
        "Buyer_Journey_Label": "Vendor Evaluation",
        "Explanation": "Direct (Non-NL) visit rather than newsletter click \u2022 Engaging with late-stage comparison/evaluation content \u2022 Exploring process/solution workflows \u2022 Looking at challenge/problem-focused content",
        "Primary_Topic": "Bioprocess Manufacturing Services,CMO-CDMO,How To Safely Handle Your Antibody Drug Conjugate",
        "Potential_Vendors": "Cytiva, Sartorius, Thermo Fisher Scientific, Repligen, Pall (Cytiva), MilliporeSigma",
        "Vendors_Evaluated": "Cytiva, Lonza, MilliporeSigma",
        "Buyer_Intensity_Flags": "\ud83d\udd25 Non-NL engagement, \ud83d\udcc4 Late-stage content, \ud83d\udd04 Deep process interest",
        "Behavioral_Trigger": "GMP / clinical manufacturing, Vendor/option comparison",
        "External_Trigger (press release info, etc)": "",
        "Reason_to_Reach_Out": "Actively comparing solutions in Bioprocess Manufacturing Services,CMO-CDMO,How To Safely Handle Your Antibody Drug Conjugate; good timing for targeted outreach."
      },
      {
        "Reader Company": "Primrose Bio",
        "First Name": "Andrew",
        "Last Name": "Burch",
        "Title": "CEO",
        "Total_Engagements": 14,
        "Buyer_Journey_Label": "Vendor Evaluation",
        "Explanation": "Direct (Non-NL) visit rather than newsletter click \u2022 Engaging with late-stage comparison/evaluation content \u2022 Exploring process/solution workflows \u2022 Looking at challenge/problem-focused content",
        "Primary_Topic": "Biologic,Bioprocess Manufacturing Services,Essential Insights Into Linker Chemistry For Antibody Drug Conjugates (ADCs)",
        "Potential_Vendors": "Cytiva, Sartorius, Thermo Fisher Scientific, Repligen, Pall (Cytiva), MilliporeSigma",
        "Vendors_Evaluated": "Cytiva, Thermo Fisher, Thermo Fisher Scientific",
        "Buyer_Intensity_Flags": "\ud83d\udd25 Non-NL engagement, \ud83d\udcc4 Late-stage content, \ud83d\udd04 Deep process interest",
        "Behavioral_Trigger": "GMP / clinical manufacturing, Vendor/option comparison",
        "External_Trigger (press release info, etc)": "",
        "Reason_to_Reach_Out": "Actively comparing solutions in Biologic,Bioprocess Manufacturing Services,Essential Insights Into Linker Chemistry For Antibody Drug Conjugates (ADCs); good timing for targeted outreach."
      },
      {
        "Reader Company": "Biological E. Limited",
        "First Name": "Ankur",
        "Last Name": "Gupta",
        "Title": "Knowledge Management Practice Lead",
        "Total_Engagements": 8,
        "Buyer_Journey_Label": "Vendor Evaluation",
        "Explanation": "Direct (Non-NL) visit rather than newsletter click \u2022 Engaging with late-stage comparison/evaluation content \u2022 Exploring process/solution workflows \u2022 Looking at challenge/problem-focused content",
        "Primary_Topic": "& Analytical Solutions - November 2025,Bio-Expo Live: Bioprocess Quality,Data",
        "Potential_Vendors": "Waters, Agilent, Thermo Fisher Scientific, SCIEX, Shimadzu",
        "Vendors_Evaluated": "MilliporeSigma, Thermo Fisher, Thermo Fisher Scientific",
        "Buyer_Intensity_Flags": "\ud83d\udd25 Non-NL engagement, \ud83d\udcc4 Late-stage content, \ud83d\udd04 Deep process interest",
        "Behavioral_Trigger": "GMP / clinical manufacturing, Vendor/option comparison",
        "External_Trigger (press release info, etc)": "",
        "Reason_to_Reach_Out": "Actively comparing solutions in & Analytical Solutions - November 2025,Bio-Expo Live: Bioprocess Quality,Data; good timing for targeted outreach."
      },
      {
        "Reader Company": "Pharmaron Biologics Ltd.",
        "First Name": "Beata",
        "Last Name": "Adamiak",
        "Title": "Senior Manager (Process Sciences)",
        "Total_Engagements": 12,
        "Buyer_Journey_Label": "Vendor Evaluation",
        "Explanation": "Direct (Non-NL) visit rather than newsletter click \u2022 Engaging with late-stage comparison/evaluation content \u2022 Exploring process/solution workflows \u2022 Looking at challenge/problem-focused content",
        "Primary_Topic": "& Analytical Solutions - November 2025,Assays,Bio-Expo Live: Bioprocess Quality",
        "Potential_Vendors": "Waters, Agilent, Thermo Fisher Scientific, SCIEX, Shimadzu",
        "Vendors_Evaluated": "MilliporeSigma, Thermo Fisher, Thermo Fisher Scientific",
        "Buyer_Intensity_Flags": "\ud83d\udd25 Non-NL engagement, \ud83d\udcc4 Late-stage content, \ud83d\udd04 Deep process interest",
        "Behavioral_Trigger": "GMP / clinical manufacturing, Vendor/option comparison",
        "External_Trigger (press release info, etc)": "",
        "Reason_to_Reach_Out": "Actively comparing solutions in & Analytical Solutions - November 2025,Assays,Bio-Expo Live: Bioprocess Quality; good timing for targeted outreach."
      }
    ]
  }
}